Logo


Swedish firm Recipharm buys Kemwell businesses for Rs 1360 cr

Two separate agreements have been signed for this - while first comprises US and Swedish operations, the second comprises operations in India

Swedish firm Recipharm buys Kemwell businesses for Rs 1360 cr

Recipharm AB, a Swedish company, active as a pharmaceutical contract development and manufacturing organisation (CDMO), has agreed to acquire Kemwell’s pharmaceutical contract development and manufacturing businesses in India, US and Sweden in a strategic deal worth $ 205 million (about Rs 1360 crore).   Anurag Bagaria, managing director of Kemwell, commented, “I am delighted about the combination of Kemwell’s pharmaceutical business with Recipharm, both of which have many complementary capabilities. I am confident that together we will be even more successful and ...